Related Experiment Video
Updated: Mar 19, 2026
09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.6K
Combined clinical and genetic testing algorithm for cervical cancer diagnosis
Yu-Ligh Liou1,2,3, Tao-Lan Zhang1, Tian Yan4
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Hunan, 410078 People's Republic of China.
Clinical Epigenetics
|June 14, 2016
Summary
New algorithms combining gynecologic exams with molecular tests like PAX1, ZNF582 methylation, and HPV16/18 improve cervical cancer screening accuracy. These methods offer precise diagnostics for areas with limited resources and high mortality rates.
Area of Science:
- Oncology
- Molecular Diagnostics
- Public Health
Background:
- Opportunistic cervical cancer screening is vital in developing nations.
- Current methods aim to reduce cervical cancer incidence.
- This study sought to enhance diagnostic accuracy through combined clinical and molecular testing.
Purpose of the Study:
- To develop and validate clinical risk factor algorithms for cervical cancer diagnosis.
- To integrate gynecologic examination findings with molecular test results (PAX1/ZNF582 methylation, HPV16/18).
- To improve the precision and objectivity of cervical cancer diagnostics in resource-limited settings.
Main Methods:
- Quantitative methylation-specific PCR was used to determine delta Cp of methylated PAX1 and ZNF582 in a training set.
- Sensitivity and specificity of individual and combined gene tests were calculated.
- Three algorithms integrating gynecologic findings and genetic tests were compared in a randomized case-control study (449 women).
Main Results:
- A significant association was found between cervical intraepithelial neoplasia grade 3+ (CIN3+) and combined methylated PAX1/ZNF582 with HPV16/18 (OR: 15.52).
- Sensitivities for CIN3+ detection were 89.2% (PAX1/HPV16/18) and 85.4% (ZNF582/HPV16/18), with specificities of 76.0% and 80.1%, respectively.
- Two validated algorithms demonstrated 100% sensitivity for cervical cancer detection, reducing unnecessary colposcopy referrals.
Conclusions:
- Developed algorithms enhance precise and objective cervical cancer diagnostics.
- These methods are suitable for outpatient settings in countries with high mortality and low screening rates.
- The algorithms address challenges in areas with uneven resource distribution, improving screening effectiveness.
